Latest Cancer: Kidney news
Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC
posted September 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Belzutifan Active in Renal Cell Carcinoma Associated With VHL Disease
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Treatments Compared for Advanced Renal Cell Carcinoma
posted December 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Adjuvant Pembrolizumab Beneficial in Renal Cell Carcinoma
posted August 19th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Paternal Exposure to Valproate Not Linked to Offspring Neurodevelopmental Disorders 
Drug Retention in Spondyloarthritis Varies With Socioeconomic Status 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing Related Articles
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries 
Global Burden of Renal Cancer Expected to Double by 2050 Monthly Specialist Briefings
Stay Connected
